Brief: Delcath Systems Announces New Drug Application Resubmission For Hepzato Kit
14/02/2023 15:10
Delcath Systems Inc DCTH.O :
* DELCATH SYSTEMS ANNOUNCES NEW DRUG APPLICATION
RESUBMISSION FOR
HEPZATO KIT
* DELCATH SYSTEMS INC - RESUBMISSION IS IN RESPONSE TO A
SEPTEMBER
12, 2013 COMPLETE RESPONSE LETTER (CRL) FROM FDA
* DELCATH SYSTEMS INC - LOOK FORWARD TO RECEIVING FEEDBACK
FROM
FDA REGARDING A PDUFA DATE WITHIN 30 DAY
Source text for Eikon: ID:nPn3l5ryPa
Further company coverage: DCTH.O
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Delcath Systems Q1 revenue beats on Hepzato growth
Brief: Delcath Systems Announces Publication Of Chopin Clinical Trial Results In The Lancet Oncology
Delcath Q4 revenue rises 37%, beats estimates
Brief: Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)